PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients

SIMPLE SUMMARY: This review focuses on the effects that a class of drugs, PI3Kδ inhibitors, used for the treatment of patients with lymphoma can have not on the neoplastic cells but on the normal cells and how this effect can modulate the immune response and potentially contribute to the anti-tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantelli, Chiara, Argnani, Lisa, Zinzani, Pier Luigi, Bertoni, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582887/
https://www.ncbi.nlm.nih.gov/pubmed/34771694
http://dx.doi.org/10.3390/cancers13215535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582887/
https://www.ncbi.nlm.nih.gov/pubmed/34771694
http://dx.doi.org/10.3390/cancers13215535

Ejemplares similares